Guanxinning Tablet Attenuates Coronary Atherosclerosis via Regulating the Gut Microbiota and Their Metabolites in Tibetan Minipigs Induced by a High-Fat Diet
Coronary atherosclerosis (CA) is a chronic and evolving inflammatory disease characterized by the build-up of atherosclerotic plaque in the wall of coronary arteries. Guanxinning tablet (GXNT) is a novel Chinese medicine formula, which has been clinically used to treat coronary heart disease for man...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2022/7128230 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832555189942353920 |
|---|---|
| author | Qinqin Yang Yanyun Xu Liye Shen Yongming Pan Junjie Huang Quanxin Ma Chen Yu Jiaojiao Chen Yu Chen Minli Chen |
| author_facet | Qinqin Yang Yanyun Xu Liye Shen Yongming Pan Junjie Huang Quanxin Ma Chen Yu Jiaojiao Chen Yu Chen Minli Chen |
| author_sort | Qinqin Yang |
| collection | DOAJ |
| description | Coronary atherosclerosis (CA) is a chronic and evolving inflammatory disease characterized by the build-up of atherosclerotic plaque in the wall of coronary arteries. Guanxinning tablet (GXNT) is a novel Chinese medicine formula, which has been clinically used to treat coronary heart disease for many years. However, the potential mechanism for treating CA remains unclear. Thus, the study was aimed at investigating the therapeutic effect of GXNT on CA and further explore the underlying mechanisms from the perspective of gut microbiota. Following the establishment of a CA model in Tibetan minipigs, GXNT was orally administrated. We simultaneously detected blood lipid levels, observed ventricular function using ultrasound examination, measured platelet aggregation, and checked changes in inflammatory factors, oxidative stress factors, and vascular endothelial injury-related indexes applying ELISA assays. Histopathological changes of coronary artery tissue were subsequently evaluated using Sudan IV staining, HE staining, Oil red “O” staining, and immunohistochemistry assays. Finally, alterations of the gut microbiota and microbial metabolites were detected using metagenomic sequencing and targeted metabolomics, respectively. The results have suggested that GXNT could regulate dyslipidemia, improve heart function, and inhibit the levels of ox-LDL, CRP, TNF-α, IL-1β, SOD, MDA, vWF, and ET-1, as well as platelet aggregation. Additionally, histopathological findings revealed that GXNT could reduce lipid deposition, alleviate AS lesions, and restrain the expressions of NF-κB, TNF-α, and MMP-9. Furthermore, the composition of the gut microbiota was altered. Specifically, GXNT could upregulate the relative abundance of Prevotellaceae and Prevotella and downregulate the abundance of Proteobacteria, Enterobacteriaceae, and Escherichia. As for microbial metabolites, GXNT could increase fecal propionic acid, butyric acid, and LCA-3S and decrease fecal TMA-related metabolites, CDCA, and serum TMAO. In sum, the results showed that GXNT had a satisfactory anti-CA effect, and the mechanism was closely associated with modulating gut microbiota and related metabolites. |
| format | Article |
| id | doaj-art-887c7f0fb83c4e27a91d31d88ac95e9f |
| institution | Kabale University |
| issn | 2314-7156 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-887c7f0fb83c4e27a91d31d88ac95e9f2025-02-03T05:49:24ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/7128230Guanxinning Tablet Attenuates Coronary Atherosclerosis via Regulating the Gut Microbiota and Their Metabolites in Tibetan Minipigs Induced by a High-Fat DietQinqin Yang0Yanyun Xu1Liye Shen2Yongming Pan3Junjie Huang4Quanxin Ma5Chen Yu6Jiaojiao Chen7Yu Chen8Minli Chen9Academy of Chinese Medicine & Institute of Comparative MedicineSchool of Pharmaceutical SciencesSchool of Pharmaceutical SciencesAcademy of Chinese Medicine & Institute of Comparative MedicineAcademy of Chinese Medicine & Institute of Comparative MedicineAcademy of Chinese Medicine & Institute of Comparative MedicineAcademy of Chinese Medicine & Institute of Comparative MedicineAcademy of Chinese Medicine & Institute of Comparative MedicineDepartment of Experimental AnimalsAcademy of Chinese Medicine & Institute of Comparative MedicineCoronary atherosclerosis (CA) is a chronic and evolving inflammatory disease characterized by the build-up of atherosclerotic plaque in the wall of coronary arteries. Guanxinning tablet (GXNT) is a novel Chinese medicine formula, which has been clinically used to treat coronary heart disease for many years. However, the potential mechanism for treating CA remains unclear. Thus, the study was aimed at investigating the therapeutic effect of GXNT on CA and further explore the underlying mechanisms from the perspective of gut microbiota. Following the establishment of a CA model in Tibetan minipigs, GXNT was orally administrated. We simultaneously detected blood lipid levels, observed ventricular function using ultrasound examination, measured platelet aggregation, and checked changes in inflammatory factors, oxidative stress factors, and vascular endothelial injury-related indexes applying ELISA assays. Histopathological changes of coronary artery tissue were subsequently evaluated using Sudan IV staining, HE staining, Oil red “O” staining, and immunohistochemistry assays. Finally, alterations of the gut microbiota and microbial metabolites were detected using metagenomic sequencing and targeted metabolomics, respectively. The results have suggested that GXNT could regulate dyslipidemia, improve heart function, and inhibit the levels of ox-LDL, CRP, TNF-α, IL-1β, SOD, MDA, vWF, and ET-1, as well as platelet aggregation. Additionally, histopathological findings revealed that GXNT could reduce lipid deposition, alleviate AS lesions, and restrain the expressions of NF-κB, TNF-α, and MMP-9. Furthermore, the composition of the gut microbiota was altered. Specifically, GXNT could upregulate the relative abundance of Prevotellaceae and Prevotella and downregulate the abundance of Proteobacteria, Enterobacteriaceae, and Escherichia. As for microbial metabolites, GXNT could increase fecal propionic acid, butyric acid, and LCA-3S and decrease fecal TMA-related metabolites, CDCA, and serum TMAO. In sum, the results showed that GXNT had a satisfactory anti-CA effect, and the mechanism was closely associated with modulating gut microbiota and related metabolites.http://dx.doi.org/10.1155/2022/7128230 |
| spellingShingle | Qinqin Yang Yanyun Xu Liye Shen Yongming Pan Junjie Huang Quanxin Ma Chen Yu Jiaojiao Chen Yu Chen Minli Chen Guanxinning Tablet Attenuates Coronary Atherosclerosis via Regulating the Gut Microbiota and Their Metabolites in Tibetan Minipigs Induced by a High-Fat Diet Journal of Immunology Research |
| title | Guanxinning Tablet Attenuates Coronary Atherosclerosis via Regulating the Gut Microbiota and Their Metabolites in Tibetan Minipigs Induced by a High-Fat Diet |
| title_full | Guanxinning Tablet Attenuates Coronary Atherosclerosis via Regulating the Gut Microbiota and Their Metabolites in Tibetan Minipigs Induced by a High-Fat Diet |
| title_fullStr | Guanxinning Tablet Attenuates Coronary Atherosclerosis via Regulating the Gut Microbiota and Their Metabolites in Tibetan Minipigs Induced by a High-Fat Diet |
| title_full_unstemmed | Guanxinning Tablet Attenuates Coronary Atherosclerosis via Regulating the Gut Microbiota and Their Metabolites in Tibetan Minipigs Induced by a High-Fat Diet |
| title_short | Guanxinning Tablet Attenuates Coronary Atherosclerosis via Regulating the Gut Microbiota and Their Metabolites in Tibetan Minipigs Induced by a High-Fat Diet |
| title_sort | guanxinning tablet attenuates coronary atherosclerosis via regulating the gut microbiota and their metabolites in tibetan minipigs induced by a high fat diet |
| url | http://dx.doi.org/10.1155/2022/7128230 |
| work_keys_str_mv | AT qinqinyang guanxinningtabletattenuatescoronaryatherosclerosisviaregulatingthegutmicrobiotaandtheirmetabolitesintibetanminipigsinducedbyahighfatdiet AT yanyunxu guanxinningtabletattenuatescoronaryatherosclerosisviaregulatingthegutmicrobiotaandtheirmetabolitesintibetanminipigsinducedbyahighfatdiet AT liyeshen guanxinningtabletattenuatescoronaryatherosclerosisviaregulatingthegutmicrobiotaandtheirmetabolitesintibetanminipigsinducedbyahighfatdiet AT yongmingpan guanxinningtabletattenuatescoronaryatherosclerosisviaregulatingthegutmicrobiotaandtheirmetabolitesintibetanminipigsinducedbyahighfatdiet AT junjiehuang guanxinningtabletattenuatescoronaryatherosclerosisviaregulatingthegutmicrobiotaandtheirmetabolitesintibetanminipigsinducedbyahighfatdiet AT quanxinma guanxinningtabletattenuatescoronaryatherosclerosisviaregulatingthegutmicrobiotaandtheirmetabolitesintibetanminipigsinducedbyahighfatdiet AT chenyu guanxinningtabletattenuatescoronaryatherosclerosisviaregulatingthegutmicrobiotaandtheirmetabolitesintibetanminipigsinducedbyahighfatdiet AT jiaojiaochen guanxinningtabletattenuatescoronaryatherosclerosisviaregulatingthegutmicrobiotaandtheirmetabolitesintibetanminipigsinducedbyahighfatdiet AT yuchen guanxinningtabletattenuatescoronaryatherosclerosisviaregulatingthegutmicrobiotaandtheirmetabolitesintibetanminipigsinducedbyahighfatdiet AT minlichen guanxinningtabletattenuatescoronaryatherosclerosisviaregulatingthegutmicrobiotaandtheirmetabolitesintibetanminipigsinducedbyahighfatdiet |